|
Name |
4-Methoxyphenol
|
Molecular Formula | C7H8O2 | |
IUPAC Name* |
4-methoxyphenol
|
|
SMILES |
COC1=CC=C(C=C1)O
|
|
InChI |
InChI=1S/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H3
|
|
InChIKey |
NWVVVBRKAWDGAB-UHFFFAOYSA-N
|
|
Synonyms |
4-Methoxyphenol; Mequinol; 150-76-5; 4-Hydroxyanisole; p-Hydroxyanisole; p-Methoxyphenol; Phenol, 4-methoxy-; HYDROQUINONE MONOMETHYL ETHER; Leucobasal; MEHQ; Leucodine B; Mechinolum; P-Guaiacol; Hydroquinone methyl ether; Novo-Dermoquinona; HQMME; p-Hydroxymethoxybenzene; para-methoxyphenol; 1-Hydroxy-4-methoxybenzene; Monomethyl ether hydroquinone; 4-Methoxy-phenol; PMF (antioxidant); Phenol, p-methoxy-; USAF AN-7; Mono methyl ether hydroquinone; NSC 4960; MFCD00002332; BMS 181158; BMS-181158; NSC-4960; 6HT8U7K3AM; DTXSID4020828; CHEBI:69441; NSC4960; Mequinol (INN); NCGC00091390-02; MEQUINOL [INN]; DSSTox_CID_828; DSSTox_RID_75814; DSSTox_GSID_20828; Mechinolo [DCIT]; Mequinolum; Mechinolo; Mequinolum [INN-Latin]; CAS-150-76-5; CCRIS 5531; HSDB 4258; EINECS 205-769-8; UNII-6HT8U7K3AM; Mequinol [USAN:INN:DCF]; 4methoxyphenol; paramethoxyphenol; AI3-00841; p- methoxyphenol; p-methoxy phenol; p-methoxy-phenol; 4-methoxy phenol; Eastman HQMME; 4-(methoxy)phenol; 4HA; 4KS; para- hydroxyanisole; 4-(methyloxy)phenol; HQME; MEQUINOL [HSDB]; MEQUINOL [USAN]; Mequinol (USAN/INN); Mequinol, INN, USAN; MEQUINOL [VANDF]; PHENOL,4-METHOXY; hydroxyquinone methyl ether; MEQUINOL [MART.]; hydroquinone monomethylether; CHEMBL544; MEQUINOL [WHO-DD]; EC 205-769-8; NCIMech_000709; WLN: QR DO1; SCHEMBL21009; hydroquinone mono methyl ether; MLS002454409; MEQUINOL [ORANGE BOOK]; GTPL6827; ZINC1684; P-HYDROXYANISOLE [INCI]; SOLAGE COMPONENT MEQUINOL; SCHEMBL12015251; BDBM36295; HMS2270F04; HMS3264P13; HMS3652O08; Pharmakon1600-00212037; MEQUINOL COMPONENT OF SOLAGE; 4-Methoxyphenol, analytical standard; Tox21_111125; Tox21_202367; Tox21_302876; CCG-35855; NSC760357; STL199145; AKOS000119852; Tox21_111125_1; AC-3292; AM10685; CS-W019963; DB09516; NSC-760357; PS-3375; SB40551; 4-Methoxyphenol, ReagentPlus(R), 99%; NCGC00091390-01; NCGC00091390-03; NCGC00091390-04; NCGC00256552-01; NCGC00259916-01; BP-23487; HQMME; HYDROXYQUINONE METHYL ETHER; HY-30270; NCI60_004190; SMR001252253; DB-003965; FT-0618865; M0123; S4077; SW219760-1; 4-Methoxyphenol, purum, >=98.0% (HPLC); EN300-19649; 4-Methoxyphenol, SAJ first grade, >=97.0%; D04926; P17835; AB00641905_06; AB00641905_07; A809071; SR-01000865565; Q-200491; Q2862455; SR-01000865565-2; BRD-K45216060-001-06-8; F9995-1658; Z104474598; 4-Methoxybenzyl S-(4,6-dimethylpyrimidin-2-yl)thiocarbonate
|
|
CAS | 150-76-5 | |
PubChem CID | 9015 | |
ChEMBL ID | CHEMBL544 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 124.14 | ALogp: | 1.3 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 29.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 9 | QED Weighted: | 0.619 |
Caco-2 Permeability: | -4.36 | MDCK Permeability: | 0.00001750 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.137 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.277 |
Blood-Brain-Barrier Penetration (BBB): | 0.121 | Plasma Protein Binding (PPB): | 65.65% |
Volume Distribution (VD): | 2.095 | Fu: | 20.55% |
CYP1A2-inhibitor: | 0.865 | CYP1A2-substrate: | 0.936 |
CYP2C19-inhibitor: | 0.64 | CYP2C19-substrate: | 0.692 |
CYP2C9-inhibitor: | 0.113 | CYP2C9-substrate: | 0.946 |
CYP2D6-inhibitor: | 0.466 | CYP2D6-substrate: | 0.907 |
CYP3A4-inhibitor: | 0.099 | CYP3A4-substrate: | 0.308 |
Clearance (CL): | 13.468 | Half-life (T1/2): | 0.891 |
hERG Blockers: | 0.042 | Human Hepatotoxicity (H-HT): | 0.042 |
Drug-inuced Liver Injury (DILI): | 0.069 | AMES Toxicity: | 0.084 |
Rat Oral Acute Toxicity: | 0.385 | Maximum Recommended Daily Dose: | 0.027 |
Skin Sensitization: | 0.829 | Carcinogencity: | 0.667 |
Eye Corrosion: | 0.973 | Eye Irritation: | 0.994 |
Respiratory Toxicity: | 0.411 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000221 | 0.613 | D03UOT | 0.516 | ||||
ENC000223 | 0.606 | D0U5QK | 0.447 | ||||
ENC000086 | 0.567 | D0W1RY | 0.436 | ||||
ENC000740 | 0.559 | D0H6TP | 0.408 | ||||
ENC000195 | 0.528 | D0B3QM | 0.378 | ||||
ENC000201 | 0.528 | D02WAB | 0.378 | ||||
ENC001021 | 0.516 | D02DPU | 0.373 | ||||
ENC000310 | 0.514 | D01CRB | 0.364 | ||||
ENC001460 | 0.514 | D0DJ1B | 0.333 | ||||
ENC001441 | 0.488 | D0P1UX | 0.328 |